Ifp Advisors, Inc Synthetic Biologics, Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$1.9 - $2.9 $7,267 - $11,092	3,825 New	3,825 $13,000
Q2 2022 Aug 12, 2022	SELL	$1.9 - $2.9 $7,267 - $11,092	-3,825 Closed	0 $0
Q1 2022 Sep 06, 2022	SELL	$2.3 - $4.3 $23,000 - $43,000	-10,000 Reduced 72.33%	3,825 $11,000
Q4 2021 Jan 12, 2022	BUY	$2.7 - $4.5 $27,000 - $45,000	10,000 Added 261.44%	13,825 $5,000
Q3 2021 Oct 06, 2021	BUY	$4.3 - $5.8 $215 - $290	50 Added 1.32%	3,825 $3,000
Q1 2021 Apr 30, 2021	BUY	$5.0 - $11.7 $300 - $702	60 Added 1.62%	3,775 $3,000
Q3 2019 Nov 07, 2019	BUY	$3.9 - $5.9 $14,488 - $21,918	3,715 New	3,715 $2,000
Q1 2019 May 15, 2019	SELL	$5.9 - $8.1 $21,918 - $30,091	-3,715 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$5.2 - $26.8 $5,054 - $26,049	-972 Reduced 20.74%	3,715 $20,000
Q3 2018 Oct 25, 2018	BUY	$20.4 - $80.5 $95,614 - $377,303	4,687 New	4,687 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.